The adenosine A2B receptor is the least well characterized of the four adenosine subtypes due to the lack of potent and selective agonists and antagonists. Despite the widespread distribution of A2B receptor mRNA, little information is available with regard to their function. The characterization of A2B receptors, through radioligand binding studies, has been performed, until now, by using low-affinity and non-selective antagonists like 1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX),(4-(2- [7-amino-2-(2-furyl)-[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5- ylamino]ethyl)-phenol ([3H]ZM 241385) and 3-(3, 4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine ([125I]ABOPX). Recently, high-affinity radioligands for A2B receptors, [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro- 2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy] acetamide ([3H]MRS 1754), N-(2-(2-Phenyl-6-[4-(2,2,3,3- tetratritrio-3-phenylpropyl)-piperazine-1-carbonyl]-7H-pyrrolo[ 2,3-d]pyrimidin-4-ylamino)-ethyl)-acetamide ([3H] OSIP339391) and N-benzo[1,3]dioxol-5-yl-2-[5-(1,3- dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-1- methyl-1H-pyrazol-3-yloxy]-acetamide] ([3H]MRE 2029F20), have been introduced. This minireview offers an overview of these recently developed radioligands and the most important applications of drugs towards A2B receptors.

Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors

GESSI, Stefania;VARANI, Katia;MERIGHI, Stefania;BARALDI, Pier Giovanni;BOREA, Pier Andrea
2006

Abstract

The adenosine A2B receptor is the least well characterized of the four adenosine subtypes due to the lack of potent and selective agonists and antagonists. Despite the widespread distribution of A2B receptor mRNA, little information is available with regard to their function. The characterization of A2B receptors, through radioligand binding studies, has been performed, until now, by using low-affinity and non-selective antagonists like 1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX),(4-(2- [7-amino-2-(2-furyl)-[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5- ylamino]ethyl)-phenol ([3H]ZM 241385) and 3-(3, 4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine ([125I]ABOPX). Recently, high-affinity radioligands for A2B receptors, [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro- 2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy] acetamide ([3H]MRS 1754), N-(2-(2-Phenyl-6-[4-(2,2,3,3- tetratritrio-3-phenylpropyl)-piperazine-1-carbonyl]-7H-pyrrolo[ 2,3-d]pyrimidin-4-ylamino)-ethyl)-acetamide ([3H] OSIP339391) and N-benzo[1,3]dioxol-5-yl-2-[5-(1,3- dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-1- methyl-1H-pyrazol-3-yloxy]-acetamide] ([3H]MRE 2029F20), have been introduced. This minireview offers an overview of these recently developed radioligands and the most important applications of drugs towards A2B receptors.
2006
Gessi, Stefania; Varani, Katia; Merighi, Stefania; E., Leung; S., Mac Lennan; Baraldi, Pier Giovanni; Borea, Pier Andrea
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/523629
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
social impact